Target Name: CCDC54
NCBI ID: G84692
Review Report on CCDC54 Target / Biomarker Content of Review Report on CCDC54 Target / Biomarker
CCDC54
Other Name(s): Coiled-coil domain-containing protein 54 | coiled-coil domain containing 54 | testicular tissue protein Li 33 | SP17 | Testes development-related NYD-SP17 | NYD-SP17 | testes development-related NYD-SP17 | sperm protein 17 | Testis development protein NYD-SP17 | CCD54_HUMAN | Sperm protein 17 | testis development protein NYD-SP17 | Coiled-coil domain containing 54

CDCD54: A Potential Drug Target and Biomarker

CCDC54 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the C-type water-type superfamily and is characterized by the presence of a coiled-coil domain. The CCDC54 protein is of particular interest as it has been identified as a potential drug target and biomarker.

The CCDC54 protein is involved in a variety of physiological processes in the body, including cell signaling, DNA replication, and chromatin regulation. It is a key regulator of the microtubule network, which is a protein structure that is involved in cell movement and division. The microtubule network is composed of two sets of proteins that are organized in a highly organized structure, known as the microtubules. The CCDC54 protein is one of the proteins that is involved in the regulation of the microtubule network.

One of the key functions of the CCDC54 protein is its role in chromatin regulation. Chromatin is the genetic material that makes up the chromosomes in the nucleus of a cell. The CCDC54 protein is involved in the regulation of the structure and function of chromatin. This includes the regulation of the replication of DNA, the regulation of gene expression, and the regulation of the apoptosis of cells.

In addition to its role in chromatin regulation, the CCDC54 protein is also involved in cell signaling. It is a key regulator of the PI3K/Akt signaling pathway, which is involved in a variety of cellular processes, including cell survival, growth, and angiogenesis. The CCDC54 protein is involved in the regulation of the PI3K/Akt signaling pathway by controlling the activity of the protein kinase B.

The CCDC54 protein is also of interest as a potential drug target. Its involvement in the regulation of the microtubule network and chromatin regulation makes it an attractive target for small molecules that can modulate these processes. In addition, the CCDC54 protein is also involved in cell signaling and may be a potential target for drugs that target signaling pathways involved in cell survival and angiogenesis.

The CCDC54 protein is also of interest as a potential biomarker. Its involvement in the regulation of the microtubule network and chromatin regulation makes it a potential target for diagnostic tests that are used to monitor the health of tissues and organs. In addition, the CCDC54 protein may be a useful biomarker for evaluating the effectiveness of drugs that are used to treat conditions that are characterized by changes in the microtubule network and chromatin regulation.

In conclusion, the CCDC54 protein is a protein that is of particular interest as a potential drug target and biomarker. Its involvement in the regulation of the microtubule network and chromatin regulation makes it a potential target for small molecules that can modulate these processes. Further research is needed to fully understand the role of the CCDC54 protein in cellular processes and to develop effective drugs that can target it.

Protein Name: Coiled-coil Domain Containing 54

The "CCDC54 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC54 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CCDC57 | CCDC6 | CCDC60 | CCDC61 | CCDC62 | CCDC63 | CCDC65 | CCDC66 | CCDC68 | CCDC69 | CCDC7 | CCDC70 | CCDC71 | CCDC71L | CCDC73 | CCDC74A | CCDC74B | CCDC77 | CCDC78 | CCDC8 | CCDC80 | CCDC81 | CCDC82 | CCDC83 | CCDC85A | CCDC85B | CCDC85C | CCDC86 | CCDC87 | CCDC88A | CCDC88B | CCDC88C | CCDC89 | CCDC9 | CCDC90B | CCDC91 | CCDC92 | CCDC92B | CCDC93 | CCDC96 | CCDC97 | CCDC9B | CCDST | CCEPR | CCER1 | CCER2 | CCHCR1 | CCIN | CCK | CCK receptor | CCKAR | CCKBR | CCL1 | CCL11 | CCL13 | CCL14 | CCL15 | CCL15-CCL14 | CCL16 | CCL17 | CCL18 | CCL19 | CCL2 | CCL20 | CCL21 | CCL22 | CCL23 | CCL24 | CCL25 | CCL26 | CCL27 | CCL28 | CCL3 | CCL3-AS1 | CCL3L1 | CCL3L3 | CCL3P1 | CCL4 | CCL4L1 | CCL4L2 | CCL5 | CCL7 | CCL8 | CCM2 | CCM2L | CCN1 | CCN2 | CCN3 | CCN4 | CCN5 | CCN6 | CCNA1 | CCNA2 | CCNB1 | CCNB1IP1 | CCNB2 | CCNB2P1 | CCNB3 | CCNC | CCND1